Navigating a lung cancer diagnosis
by Brandpoint (ARA) Sponsored Content
Jun 11, 2013 | 29110 views | 0 0 comments | 1192 1192 recommendations | email to a friend | print
(BPT) - Far too often, people make the mistake of assuming that lung cancer only affects people who smoke, but the disease can affect anyone. In fact, approximately 10 percent of patients with lung cancer have never smoked and approximately 50 percent of newly diagnosed lung cancer patients have already quit smoking.

Until recently, the “one-size-fits-all” approach was the standard way to treat lung cancer patients. However, there are several different types of the disease, and the treatment approach for some patients may be determined by the underlying genetic makeup of his or her tumor.

“By working with my doctor and asking questions, we were able to create a treatment plan that corresponded to my needs as an individual patient, not as a disease,” says Jill Feldman, a 43-year-old lung cancer patient. Feldman is involved with Lung Cancer Profiles (www.lungcancerprofiles.com),  a national campaign developed by six lung cancer advocacy groups and Pfizer Oncology, which aims to reduce the stigma attached to lung cancer and raise awareness of molecular testing.

Dr.­ Shane Dormady, Valley Medical Oncology Consultants, is a leading expert in the field and has been working with lung cancer patients for more than 10 years. He has witnessed how stressful it can be for patients when they are diagnosed with lung cancer, and he understands the multitude of questions that might be running through their minds at that time.

“It’s important to research your options and get answers to three important questions early on in your lung cancer diagnosis,” says Dr. Dormady. “Patients should first ask their doctor what type of lung cancer they have and then second ask whether a molecular test can help determine the genetic makeup of their tumor.”Dr. Dormady lastly goes on to emphasize patients should find out if there are treatments available to them based on the genetic makeup of their tumor. The treatment landscape is constantly evolving, and it’s crucial to get the answers to these questions to determine the best path forward in your cancer care. There are a variety of options available, including chemotherapy, radiation, biomarker driven therapy and enrollment in a clinical trial.

Consult with your doctor to find out if testing is right for you.

Copyright 2013 The Times-Independent. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

report abuse...

Express yourself:

We're glad to give readers a forum to express their points of view on issues important to this community. That forum is the “Letters to the Editor.” Letters to the editor may be submitted directly to The Times-Independent through this link and will be published in the print edition of the newspaper. All letters must be the original work of the letter writer – form letters will not be accepted. All letters must include the actual first and last name of the letter writer, the writer’s address, city and state and telephone number. Anonymous letters will not be accepted.

Letters may not exceed 400 words in length, must be regarding issues of general interest to the community, and may not include personal attacks, offensive language, ethnic or racial slurs, or attacks on personal or religious beliefs. Letters should focus on a single issue. Letters that proselytize or focus on theological debates will not be published. During political campaigns, The Times-Independent will not publish letters supporting or opposing any local candidate. Thank you letters are generally not accepted for publication unless the letter has a public purpose. Thank you letters dealing with private matters that compliment or complain about a business or individual will not be published. Nor will letters listing the names of individuals and/or businesses that supported a cause or event. Thank you letters about good Samaritan acts will be considered at the discretion of the newspaper.